Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)

Priscilla Bento Matos Derogis, Livia Rentas Sanches, Valdir Fernandes de Aranda, Marjorie Paris Colombini, Cristóvão Luis Pitangueira Mangueira, Marcelo Katz, Adriana Caschera Leme Faulhaber, Claudio Ernesto Albers Mendes, Carlos Eduardo dos Santos Ferreira, Carolina Nunes França, João Carlos de Campos Guerra

Open source

DOI: 10.1371/journal.pone.0171272
Published: 2017-02-07
Container: PLOS ONE
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0171272,
  title = {Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)},
  author = {Priscilla Bento Matos Derogis and Livia Rentas Sanches and Valdir Fernandes de Aranda and Marjorie Paris Colombini and Cristóvão Luis Pitangueira Mangueira and Marcelo Katz and Adriana Caschera Leme Faulhaber and Claudio Ernesto Albers Mendes and Carlos Eduardo dos Santos Ferreira and Carolina Nunes França and João Carlos de Campos Guerra},
  year = {2017},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0171272},
  url = {https://doi.org/10.1371/journal.pone.0171272}
}

RIS

TY  - JOUR
TI  - Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)
AU  - Priscilla Bento Matos Derogis
AU  - Livia Rentas Sanches
AU  - Valdir Fernandes de Aranda
AU  - Marjorie Paris Colombini
AU  - Cristóvão Luis Pitangueira Mangueira
AU  - Marcelo Katz
AU  - Adriana Caschera Leme Faulhaber
AU  - Claudio Ernesto Albers Mendes
AU  - Carlos Eduardo dos Santos Ferreira
AU  - Carolina Nunes França
AU  - João Carlos de Campos Guerra
PY  - 2017
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0171272
UR  - https://doi.org/10.1371/journal.pone.0171272
ER  -

APA

Derogis, P. B. M., Sanches, L. R., Aranda, V. F. D., Colombini, M. P., Mangueira, C. L. P., Katz, M., Faulhaber, A. C. L., Mendes, C. E. A., Ferreira, C. E. D. S., França, C. N., & Guerra, J. C. D. C. (2017). Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS). PLOS ONE. https://doi.org/10.1371/journal.pone.0171272

Source records

crossref · retrieved 2026-09-25T01:28:48.771Z